Literature DB >> 20141592

Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections.

Aya Mostafa1, Sylvia M Taylor, Mai el-Daly, Mostafa el-Hoseiny, Iman Bakr, Naglaa Arafa, Valérie Thiers, François Rimlinger, Mohamed Abdel-Hamid, Arnaud Fontanet, Mostafa K Mohamed.   

Abstract

OBJECTIVES: To estimate hepatitis C virus (HCV) incidence rates and identify risk factors for current HCV transmission with emphasis on the role of living with infected household family members in rural Egypt.
METHODS: A 4-year population-based, cohort study of seronegative villagers was conducted to identify incident HCV seroconversion cases. A risk factor questionnaire and blood samples for anti-HCV EIA-3 and HCV RNA polymerase chain reaction testing were collected at two rounds of follow-up. Incidence rates, relative risks and 95% confidence interval (CI) were calculated based on a Poisson distribution. A matched case-control analysis to explore specific behavioural predictors of infection was conducted and odds ratios were obtained by conditional logistic regression.
RESULTS: Twenty-five participants (11 females) seroconverted in 10,578 person years of follow-up (PY), (incidence rate of 2.4/1000 PY; 95% CI: 1.6-3.5). The median age at seroconversion was 26 years [interquartile range (IQR) 19-35] among males and 20 years (IQR 13-24) among females. The only significant risk factor identified for these cases was receiving injections [adjusted odds ratio (OR(adj))=3.3; 95% CI: 1.1-9.8]. Two of the 17 viraemic seroconvertors were infected with the same strain as at least one of their family members.
CONCLUSION: This study identified the important role of injections in spreading HCV infection in this rural community. National healthcare awareness and infection control programmes should be strengthened to prevent further transmission. Screening of families of infected HCV subjects should be an essential part of case management for early detection and management.

Entities:  

Mesh:

Year:  2010        PMID: 20141592     DOI: 10.1111/j.1478-3231.2009.02204.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  17 in total

1.  Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients.

Authors:  Walaa H Ahmed; Norihiro Furusyo; Saad Zaky; Abeer Sharaf Eldin; Hany Aboalam; Eiichi Ogawa; Masayuki Murata; Jun Hayashi
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

2.  Role of ITPA gene polymorphism in ribavirin-induced anemia and thrombocytopenia in Egyptian patients with chronic hepatitis C.

Authors:  Nader Nemr; Rania Kishk; Mohamed Mandour
Journal:  Indian J Gastroenterol       Date:  2016-02-16

3.  Epidemiology of hepatitis C virus exposure in Egypt: Opportunities for prevention and evaluation.

Authors:  F DeWolfe Miller; Mahmoud S Elzalabany; Sara Hassani; Diego F Cuadros
Journal:  World J Hepatol       Date:  2015-12-08

Review 4.  Hepatitis C genotype 4: The past, present, and future.

Authors:  Tawhida Y Abdel-Ghaffar; Mostafa M Sira; Suzan El Naghi
Journal:  World J Hepatol       Date:  2015-12-08

Review 5.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Authors:  Yousra A Mohamoud; Ghina R Mumtaz; Suzanne Riome; Dewolfe Miller; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2013-06-24       Impact factor: 3.090

6.  Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt.

Authors:  Lenka Benova; Susanne F Awad; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  Hepatology       Date:  2015-01-22       Impact factor: 17.425

7.  Viral transmission risk factors in an Egyptian population with high hepatitis C prevalence.

Authors:  Mary Kate Mohlman; Doa'a A Saleh; Sameera Ezzat; Mohamed Abdel-Hamid; Brent Korba; Kirti Shetty; Sania Amr; Christopher A Loffredo
Journal:  BMC Public Health       Date:  2015-10-07       Impact factor: 3.295

8.  The Association between Female Genital Cutting and Spousal HCV Infection in Egypt.

Authors:  Chris R Kenyon; Robert Colebunders
Journal:  Int J Hepatol       Date:  2014-03-20

9.  Overexpression of cyclooxygenase-2 and transforming growth factor-beta 1 is an independent predictor of poor virological response to interferon therapy in chronic HCV genotype 4 patients.

Authors:  Wafaey M Gomaa; Mohammed A Ibrahim; Mohamed E Shatat
Journal:  Saudi J Gastroenterol       Date:  2014 Jan-Feb       Impact factor: 2.485

10.  A novel method to identify routes of hepatitis C virus transmission.

Authors:  Cyrille Féray; Julie Bouscaillou; Bruno Falissard; Mostafa K Mohamed; Naglaa Arafa; Iman Bakr; Mostafa El-Hoseiny; Mai El Daly; Sherif El-Kafrawy; Sabine Plancoulaine; Mohamed Abdel-Hamid; Valérie Thiers; Arnaud Fontanet
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.